复发和难治性儿童 T 细胞急性淋巴细胞白血病治疗的基础生物学、挑战与新概念
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia.
对初始治疗复发或耐药的儿童预后极差,尽管采用强化治疗,生存率仍常低于 25%。
54.7分
★★★☆☆
ALL SOURCES
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia.
对初始治疗复发或耐药的儿童预后极差,尽管采用强化治疗,生存率仍常低于 25%。
Where do immunotherapies stand in management of acute leukemia in adults?
免疫疗法显著改变了成人急性白血病的治疗格局,尤其是在B细胞急性淋巴细胞白血病(B-ALL)中。
CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
结果:共纳入25项CAR-T临床试验,涉及296例患者。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。